News for Cryoport, Inc. (CYRX)

Cryoport, Inc. (NASDAQ:CYRX) Strategic Agreement and Transaction with DHL Group Call March 31, 2025 8:30 AM ETCompany ParticipantsTodd Fromer - Investor...

U.S. stocks were mixed, with the Nasdaq Composite falling over 1% on Monday. Shares of Mr. Cooper Group Inc. COOP rose sharply during Monday's session after th...

CryoPort (CYRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

PR NewswireNASHVILLE, Tenn., March 12, 2025 NASHVILLE, Tenn., March 12, 2025 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a

Release Date: March 04, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points CryoPort Inc (C

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NCYRX.OQ - Cryoport IncQ4 2024 Cryoport Inc Earnings CallMar 04, 2025 / 10:00PM GMT ===========

The following slide deck was published by Cryoport, Inc.

Start Time: 17:00 January 1, 0000 5:41 PM ETCryoport, Inc.

Quarterly Revenue: Achieved $59.5 million in Q4 2024, surpassing the estimated revenue of $58.55 million.Annual Revenue: Reported $228.4 million for FY 2024, a

CryoPort (CYRX) delivered earnings and revenue surprises of -27.27% and 0.46%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

PR NewswireNASHVILLE, Tenn., March 4, 2025 FY 2024 revenue of $228.4 million, in-line with company guidanceCommercial Cell & Gene Therapy revenue rose to $

CryoPort Inc (CYRX) is set to release its Q4 2024 earnings on Mar 4, 2025. The consensus estimate for Q4 2024 revenue is $58.55 million, and the earnings are ex

PR NewswireNASHVILLE, Tenn., Feb. 18, 2025 NASHVILLE, Tenn., Feb. 18, 2025 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a g

Overview of the Recent Transaction On December 31, 2024, Brown Capital Management LLC executed a significant transaction involving CryoPort Inc (CYRX). The firm

U.S. equity indices generated modest returns in the fourth quarter of 2024, and closed out the full year with double digit returns for the second year in a row.

PR NewswireNASHVILLE, Tenn., Jan. 21, 2025 New High-Volume Shipping System, Improving Patient Accessibility, Will Be Showcased by Cryoport Systems at Phaci

PR NewswireNASHVILLE, Tenn., Jan. 6, 2025 All Three MVE Biological Solutions' Manufacturing Facilities Are Registered With the FDA and All Applicable MVE P

Danaher (DHR), Cryoport (CYRX), and Sartorius (SARTF) stocks win buy from Guggenheim while Maravai LifeSciences (MRVI) was granted a neutral rating. Read more here.

Cryoport director Ramkumar sells shares worth $54,977